Bicocca Open Archive

Logo unimib boa
OGGIONI, NORBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.076
AS - Asia 8.381
EU - Europa 6.524
SA - Sud America 1.054
AF - Africa 193
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 22
Totale 30.294
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.264
SG - Singapore 3.250
CN - Cina 1.816
IT - Italia 1.123
DE - Germania 1.082
HK - Hong Kong 1.033
RU - Federazione Russa 932
VN - Vietnam 881
SE - Svezia 864
BR - Brasile 780
CA - Canada 702
IE - Irlanda 666
UA - Ucraina 560
GB - Regno Unito 376
FR - Francia 290
IN - India 266
KR - Corea 184
BD - Bangladesh 181
FI - Finlandia 170
AT - Austria 117
ID - Indonesia 108
AR - Argentina 106
TR - Turchia 96
JP - Giappone 88
IQ - Iraq 75
DK - Danimarca 69
ZA - Sudafrica 69
MX - Messico 65
NL - Olanda 56
PK - Pakistan 53
ES - Italia 52
PL - Polonia 47
MY - Malesia 44
SA - Arabia Saudita 42
PH - Filippine 41
CO - Colombia 34
EC - Ecuador 33
VE - Venezuela 29
IR - Iran 27
BE - Belgio 22
CL - Cile 22
AU - Australia 21
PY - Paraguay 20
UZ - Uzbekistan 20
EG - Egitto 19
MA - Marocco 19
NZ - Nuova Zelanda 19
ET - Etiopia 18
EU - Europa 18
KZ - Kazakistan 18
KE - Kenya 17
LT - Lituania 17
TH - Thailandia 17
AE - Emirati Arabi Uniti 16
JO - Giordania 16
NP - Nepal 16
TN - Tunisia 16
CH - Svizzera 14
UY - Uruguay 14
AZ - Azerbaigian 11
OM - Oman 11
IL - Israele 10
CZ - Repubblica Ceca 9
PE - Perù 9
PS - Palestinian Territory 9
AL - Albania 7
BG - Bulgaria 7
BH - Bahrain 7
JM - Giamaica 7
KG - Kirghizistan 7
LB - Libano 7
AO - Angola 6
BO - Bolivia 6
CR - Costa Rica 6
DO - Repubblica Dominicana 6
HU - Ungheria 6
NG - Nigeria 6
PA - Panama 6
RS - Serbia 6
TW - Taiwan 6
DZ - Algeria 5
GE - Georgia 5
HR - Croazia 5
TT - Trinidad e Tobago 5
HN - Honduras 4
MD - Moldavia 4
RO - Romania 4
SN - Senegal 4
SY - Repubblica araba siriana 4
BY - Bielorussia 3
GT - Guatemala 3
KW - Kuwait 3
MM - Myanmar 3
NI - Nicaragua 3
NO - Norvegia 3
PT - Portogallo 3
A1 - Anonimo 2
AF - Afghanistan, Repubblica islamica di 2
BA - Bosnia-Erzegovina 2
BZ - Belize 2
Totale 30.254
Salva come PNG Salva come JPEG
Città #
Singapore 2.039
Ann Arbor 1.879
Ashburn 1.115
Hong Kong 987
San Jose 924
Woodbridge 819
Chandler 689
Dublin 644
Jacksonville 550
Houston 538
Toronto 494
Frankfurt am Main 484
Fairfield 456
Wilmington 448
Milan 426
Dearborn 424
New York 351
Dallas 345
Santa Clara 274
Beijing 269
Ho Chi Minh City 247
Los Angeles 247
Princeton 244
Boardman 218
Chicago 214
The Dalles 197
Hanoi 183
Seattle 182
Nanjing 178
Council Bluffs 160
Cambridge 138
Shanghai 134
Seoul 129
Hefei 119
Vienna 111
Lauterbourg 108
Buffalo 92
Lachine 89
Rome 79
Dong Ket 78
Guangzhou 78
Jakarta 74
Moscow 74
Altamura 73
Lawrence 73
Orem 67
Nanchang 59
São Paulo 58
Munich 54
Helsinki 51
Fremont 45
Shenyang 44
Andover 42
Tokyo 41
Columbus 40
Grafing 40
Jinan 40
Zhengzhou 37
Da Nang 36
Jiaxing 36
Brooklyn 34
Johannesburg 34
Denver 33
Montreal 33
Nürnberg 33
San Diego 33
Atlanta 32
Tianjin 32
Baghdad 31
Changsha 31
Chennai 31
Phoenix 31
Rio de Janeiro 30
London 29
Pune 29
Falls Church 26
Ottawa 26
Daejeon 24
Haiphong 24
Hangzhou 24
Kunming 24
Ankara 23
Mountain View 23
Philadelphia 23
Warsaw 23
Hebei 22
Nuremberg 22
Basingstoke 21
Brussels 21
Istanbul 21
Sacramento 21
Boston 20
San Francisco 20
Tashkent 20
Dhaka 19
Stockholm 19
Turku 19
Addis Ababa 18
Lahore 17
Poplar 17
Totale 19.377
Salva come PNG Salva come JPEG
Nome #
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 503
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 465
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 438
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 433
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 431
Age-related changes in the function and structure of the peripheral sensory pathway in mice 423
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 414
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 411
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 402
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 394
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 382
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 349
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 338
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 334
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 330
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 323
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 323
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 320
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 317
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 315
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 315
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 313
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 308
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 302
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 301
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 299
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 297
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 297
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity 294
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth 294
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 294
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 292
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 291
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 291
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 284
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 276
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 272
Effect of proteasome inhibition on the central and peripheral nervous system 272
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 272
Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor 270
Multimodal experimental approach to the study of human neurological diseases 268
Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration 267
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse 260
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 259
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 258
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 257
Immunomodulating effects of extracorporeal photochemotherapy in rat experimental allergic encephalomyelitis 255
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 255
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 253
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 253
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 252
Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitis 250
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 250
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 249
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 249
Pixantrone (BBR2778) reduces the severity of experimental allergic encephalomyelitis 249
ENDOCANNABINOID SYSTEM IN BORTEZOMIB NEUROTOXICITY 248
Organic cation transporter 2 mRNA expression in dorsal root ganglia neurons 248
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 247
Lipoplatin tm: a less neurotoxic formulation of cisplatin 246
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 245
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 245
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 245
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 243
Effect of different chronic treatment modalities on the peripheral neurotoxicity of sagopilone in rats: a multimodal analysis 240
Granulocytes in actively induced Lewis rat EAE 239
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 237
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 237
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 236
Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats 234
Effects of palmitoylethanolamide (pea) in cisplatin-induced peripheral neuropathy in mice. 234
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 231
The new analgesic CR4056 effectively abrogates neuropathic pain induced by Bortezomib in rats 230
Characterization of spleen and spinal cord infiltrating lymphocytes during actively induced EAE in Lewis rats. 228
Erythropoietin both protects from and reverses experimental diabetic neuropathy 227
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain 227
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 225
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 224
Neurotoxicity and neuropatic pain induced by Bortezomib:evaluation of peripheral nerve fibres from a clinical to an ultrastructural level 222
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 221
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 219
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 216
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 215
Regression of diabetic complications by islet transplantation in the rat 211
Cisplatin-induced painful peripheral neuropathy severity is strain-dipendent in mice: dissecting the role of pharmacogenomics. 211
Actively induced EAE in Lewis rats: Characterization of spleen and spinal cord infiltrating lymphocytes by flow cytometry during the course of the disease 210
Peripheral neuropathy induced by chronic administration of cisplatin, taxol and bortezomib in several murine models 207
Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy 206
STUDY OF THE CALCITONIN GENE-RELATED PEPTIDE-POSITIVE INTRAEPIDERMAL NERVE FIBERS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY 206
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 206
Biodistrubution and toxicology of two PFCs intravenously injected in rats 205
Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis 204
L-serine supplementation suppresses the formation of neurotoxic deoxysphingolipids and improves neuropathy in a type 1 diabetic rat model 204
Neurotoxicity ad neuropathic pain induced by Bortezomib: evaluation of peripheral nerve fibres from a clinical to an ultrastructural level. 200
EXPRESSION OF TRPV1 AND CGRP IN SPINAL PRIMARY AFFERENT NEURONS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY TREATED WITH ANALGESICS 199
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 199
Characterization of the neurotoxicity and antineoplastic activity of bortezomib in a new myeloma-bearing murine model. 193
Chemotherapy-induced peripheral neuropathy in immunodeficient mice: new useful ready-to-use animal models 192
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis. 190
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 189
Totale 27.304
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.166
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.166
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021236 0 0 0 0 0 0 0 0 0 0 0 236
2021/20221.395 81 139 137 127 96 142 65 76 57 116 102 257
2022/20232.631 297 726 232 255 192 426 34 137 210 30 51 41
2023/20242.006 64 61 78 64 274 525 348 89 99 40 23 341
2024/20254.437 280 601 354 206 345 118 203 166 470 609 406 679
2025/202611.562 1.130 676 905 918 1.166 739 1.865 606 996 998 781 782
Totale 31.197